US 12145922
Selective D3 dopamine receptor agonists and methods of their use
granted A61PA61P25/14A61P25/16
Quick answer
US patent 12145922 (Selective D3 dopamine receptor agonists and methods of their use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Nov 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61P, A61P25/14, A61P25/16, A61P25/28